Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $12.51B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amgen USD 176.25B 24.32B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
BioCryst Pharmaceuticals USD 1.56B 14M Dec/2024
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cara Therapeutics USD 28M 11M Dec/2024
Cipla INR 1.22T 6.47B Dec/2025
Dr.Reddys Laboratories INR 1.06T 39.78B Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Grifols EUR 6.77B 773M Sep/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xencor USD 1.09B 256M Dec/2025